SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Asset, Expected Amortization, Year Four

SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Asset, Expected Amortization, Year Four

SALIX PHARMACEUTICALS LTD had Finite-Lived Intangible Asset, Expected Amortization, Year Four of $45.40 million as of 2012-12-31, per its 10-K filed 2013-03-01.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour · last filed 2013-03-01

• 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Four $45.40M.